Microba Life Sciences Limited announced that Professor Trent Munro will be joining the Company as Senior Vice President of Therapeutics. Professor Munro has over 25 years' research and development experience, including with multinational biopharmaceutical company Amgen. Professor Trent Munro commences employment with Microba on April 6, 2022 and will be leading the company's therapeutic strategy to progress its valuable drug development programs and pharma partnering engagements.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.18 AUD | -2.70% | -10.00% | 0.00% |
23/04 | Microba's Revenue Climbs 297% in Fiscal Q3 | MT |
10/04 | Microba Life Sciences Secures AU$6 Million Tax Rebate for Fiscal Year 2023; Shares Fall 5% | MT |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
0.00% | 5.5Cr | |
-22.94% | 776.96Cr | |
+75.52% | 451.04Cr | |
+6.87% | 276.34Cr | |
-2.63% | 266.99Cr | |
-49.74% | 208.81Cr | |
-19.47% | 171.77Cr | |
-19.40% | 148.8Cr | |
+20.88% | 121.95Cr | |
-45.82% | 112.4Cr |
- Stock Market
- Equities
- MAP Stock
- News Microba Life Sciences Limited
- Microba Life Sciences Limited Appoints Trent Munro as Senior Vice President of Therapeutics